DETAILED ACTION
Claims 1, 2, 4, 10-15, 17, 19, 20, and 25-28 are currently pending in the instant application. Claims 11 and 20 are withdrawn from consideration as being for non-elected subject matter. Claims 1, 2, 4, 10, 12-15, 17, and 19 are rejected. Claims 25-28 are allowable.
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Continued Examination Under 37 CFR 1.114
A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 25 August 2026 has been entered.
Election/Restrictions
Applicant’s election of Group I and the species of compound 12 (C8):
PNG
media_image1.png
123
216
media_image1.png
Greyscale
in the reply filed on 26 June 2024 has been previously acknowledged.
According to MPEP 803.02, the examiner has determined whether the elected species is allowable. Applicants’ elected species appears allowable. Therefore, the search and examination has been previously extended to the compounds of claims 25-28 which also appear allowable, and now further extended to the compound:
PNG
media_image2.png
174
328
media_image2.png
Greyscale
which is not allowable.
Claims 1, 2, 4, 10, 12-15, 17, 19, and 25-28 have been examined to the extent that they are readable on the elected embodiment, the elected species and the above mentioned compounds.
Response to Amendment and Arguments
Applicant's amendment and arguments filed 11 August 2026 have been fully considered and entered into the instant application. Applicant’s amendment has overcome the 35 USC 102(a)(1) rejection as being anticipated US Patent No. 8,501,767 as R1a in claim 1 has been amended to specify wherein the aryl is substituted with one or mor Rsb1.
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 1, 2, 4, 10, 12-15, and 17 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Krasavin et al., Tetrahedron Letters 49 (2008) 7318-7321.
Krasavin et al. discloses the compound 2b on page 7320:
PNG
media_image3.png
134
118
media_image3.png
Greyscale
. The compound 2b corresponds to Applicant’s instantly claimed invention of Formula I:
PNG
media_image4.png
126
186
media_image4.png
Greyscale
for example, wherein Y is H; m is 0; R4 can be any substituent as m is 0; X is CR3; R3 is H; R1’ is H; R1 is (C1-C4)alkyl; and R2 is C6-C10aryl which is substituted with one Rsb1 wherein Rsb1 is C(O)O(C1-C4)alkyl. In regards to claims 13 and 14, while claims 13 and 14 provide limitations to n1 and R1a, the claims do not limit R1 to being (CHR5)n1-R1a, therefore, R1 as (C1-C4) alkyl still reads on claims 13 and 14.
Claim(s) 1, 2, 4, 10, 12-15, 17, and 19 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Registry No. 268737-28-6.
Registry No. 268737-28-6 is
PNG
media_image5.png
162
328
media_image5.png
Greyscale
. The compound
PNG
media_image5.png
162
328
media_image5.png
Greyscale
corresponds to Applicant’s instantly claimed invention of Formula I:
PNG
media_image4.png
126
186
media_image4.png
Greyscale
for example, wherein Y is H; m is 0; R4 can be any substituent as m is 0; X is CR3; R3 is H; R1’ is H; R1 is (C1-C4)alkyl; and R2 is C6-C10aryl which is substituted with one Rsb1 wherein Rsb1 is C(O)O(C1-C4)alkyl. In regards to claims 13 and 14, while claims 13 and 14 provide limitations to n1 and R1a, the claims do not limit R1 to being (CHR5)n1-R1a, therefore, R1 as (C1-C4) alkyl still reads on claims 13 and 14.
Registry number 268737-28-6 is available as prior art as of 7 June 2000 the date it was indexed into the CAplus database.
See MPEP 2128: ELECTRONIC PUBLICATIONS AS PRIOR ART Status as a "Printed Publication" An electronic publication, including an on-line database or Internet publication, is considered to be a “printed publication” within the meaning of 35 U.S.C. 102(a) and (b) provided the publication was accessible to persons concerned with the art to which the document relates. See In re Wyer, 655 F.2d 221, 227, 210 USPQ 790, 795 (CCPA 1981) Since this date represents the date that each compound entered the CAPlus database on STN, this represents the date that each compound was made accessible to the public.
The aforementioned compound anticipates the instantly claimed compounds: It is further noted that for the purposes of determining if a reference is a “printed publication” for the purposes of 102(b), MPEP 2128 states the following:
PNG
media_image6.png
99
480
media_image6.png
Greyscale
where “prior art disclosures…on an on-line database are considered to be publicly available as of the date the item was publicly posted.” Since each of the database entries above lists the date that each compound was entered into the on-line database, the compounds were made publicly available as of that date in each citation, and the claims are anticipated.
Regarding the compositions of claim 19, comprising the anticipatory compounds and a carrier, the Registry entry for Registry no. 268737-28-6 discloses a mass solubility in unbuffered water at pH 7.00. This teaching in of water anticipates the claimed composition, wherein the compounds are present with a carrier (i.e., water).
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to REBECCA L ANDERSON whose telephone number is (571)272-0696. The examiner can normally be reached Monday-Friday from 6am-2pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Andrew Kosar can be reached at 571-272-0913. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/REBECCA L ANDERSON/Primary Examiner, Art Unit 1626 ____________________ 4 November 2026
Rebecca Anderson
Primary Examiner
Art Unit 1626, Group 1620
Technology Center 1600